120 results on '"Karch, Annika"'
Search Results
2. Noninvasive Diagnosis of Acute Rejection in Renal Transplant Patients Using Mass Spectrometric Analysis of Urine Samples: A Multicenter Diagnostic Phase III Trial
3. Left ventricular volume and wall stress are linked to lung function impairment in COPD
4. Partial verification bias and incorporation bias affected accuracy estimates of diagnostic studies for biomarkers that were part of an existing composite gold standard
5. The German COPD cohort COSYCONET: Aims, methods and descriptive analysis of the study population at baseline
6. Exacerbation of atopic dermatitis on grass pollen exposure in an environmental challenge chamber
7. Peripheral Artery Disease and Its Clinical Relevance in Patients with Chronic Obstructive Pulmonary Disease in the COPD and Systemic Consequences-Comorbidities Network Study
8. Redefining Cut-Points for High Symptom Burden of the Global Initiative for Chronic Obstructive Lung Disease Classification in 18,577 Patients With Chronic Obstructive Pulmonary Disease
9. Auswirkungen von partieller und differentieller Verifikation des Krankheitsstatus auf die Planung und Auswertung von Diagnosestudien
10. Comparison of MRI and VQ-SPECT as a Screening Test for Patients With Suspected CTEPH: CHANGE-MRI Study Design and Rationale
11. Randomized Comparison of Pazopanib and Doxorubicin as First-Line Treatment in Patients With Metastatic Soft Tissue Sarcoma Age 60 Years or Older: Results of a German Intergroup Study
12. Randomized Comparison of Pazopanib and Doxorubicin as First-Line Treatment in Patients With Metastatic Soft Tissue Sarcoma Age 60 Years or Older: Results of a German Intergroup Study
13. Comparison of MRI and VQ-SPECT as a Screening Test for Patients With Suspected CTEPH: CHANGE-MRI Study Design and Rationale
14. Redefining Cut-Points for High Symptom Burden of the Global Initiative for Chronic Obstructive Lung Disease Classification in 18,577 Patients With Chronic Obstructive Pulmonary Disease
15. Redefining Cut-Points for High Symptom Burden of the Global Initiative for Chronic Obstructive Lung Disease Classification in 18,577 Patients With Chronic Obstructive Pulmonary Disease
16. Keratinized mucosa width is associated with severity of peri‐implant mucositis. A cross‐sectional study
17. Complications of CT-guided lung biopsy with a non-coaxial semi-automated 18 gauge biopsy system: Frequency, severity and risk factors
18. Randomized comparison of pazopanib (PAZ) and doxorubicin (DOX) in the first line treatment of metastatic soft tissue sarcoma (STS) in elderly patients (pts): Results of a phase II study (EPAZ).
19. Additional file 3: of Costs and health-related quality of life in Alpha-1-Antitrypsin Deficient COPD patients
20. Additional file 5: of Costs and health-related quality of life in Alpha-1-Antitrypsin Deficient COPD patients
21. Cardiovascular risk in patients with alpha-1-antitrypsin deficiency
22. Additional file 4: of Costs and health-related quality of life in Alpha-1-Antitrypsin Deficient COPD patients
23. Additional file 1: of Costs and health-related quality of life in Alpha-1-Antitrypsin Deficient COPD patients
24. Additional file 1: Table S1. of Cardiovascular risk in patients with alpha-1-antitrypsin deficiency
25. Additional file 2: of Costs and health-related quality of life in Alpha-1-Antitrypsin Deficient COPD patients
26. Identifying predictors of healthcare utilization and costs in COPD patients over 18 months: first longitudinal results of the COSYCONET cohort
27. Whole-body vibration training as a workplace-based sports activity: a randomized, controlled trial
28. Risk factors for death in kidney transplant patients: analysis from a large protocol biopsy registry
29. Randomized comparison of pazopanib (PAZ) and doxorubicin (DOX) in the first line treatment of metastatic soft tissue sarcoma (STS) in elderly patients (pts): Results of a phase II study (EPAZ).
30. The contribution of symptoms and comorbidities to the economic impact of COPD: an analysis of the German COSYCONET cohort
31. The contribution of symptoms and comorbidities to the economic impact of COPD: an analysis of the German COSYCONET cohort
32. Additional file 1: Table S1. of Assessing health-related quality of life in COPD: comparing generic and disease-specific instruments with focus on comorbidities
33. Additional file 2: Table S1. of A phase II trial comparing pazopanib with doxorubicin as first-line treatment in elderly patients with metastatic or advanced soft tissue sarcoma (EPAZ): study protocol for a randomized controlled trial
34. Additional file 3: of A phase II trial comparing pazopanib with doxorubicin as first-line treatment in elderly patients with metastatic or advanced soft tissue sarcoma (EPAZ): study protocol for a randomized controlled trial
35. Additional file 1: Figure S1. of A phase II trial comparing pazopanib with doxorubicin as first-line treatment in elderly patients with metastatic or advanced soft tissue sarcoma (EPAZ): study protocol for a randomized controlled trial
36. Costs and health-related quality of life in COPD patients with α-1-antitrypsin deficiency: results of the COSYCONET cohort
37. Combatting pain after orthopedic/trauma surgery- perioperative oral extended-release tapentadol vs. extended-release oxycodone/naloxone
38. Non-invasive diagnosis of acute rejection in renal transplant patients using mass spectrometry of urine samples - a multicentre phase 3 diagnostic accuracy study
39. Additional file 1: of Non-invasive diagnosis of acute rejection in renal transplant patients using mass spectrometry of urine samples - a multicentre phase 3 diagnostic accuracy study
40. Risk factors for death in kidney transplant patients: analysis from a large protocol biopsy registry.
41. COPD influences on left heart wall stress — An analysis of the COSYCONET cohort
42. Can disease-specific questionnaires describe the effect of comorbidities on health-related quality of life in patients with COPD? A comparison of disease-specific and generic questionnaires in the COSYCONET cohort
43. Differences in the disease phenotype and comorbidities between patients with COPD and alpha-1-antitrypsin deficiency - An analysis of the COSYCONET cohort
44. ACEMg-mediated hearing preservation in cochlear implant patients receiving different electrode lengths (PROHEARING): study protocol for a randomized controlled trial
45. A phase II trial comparing pazopanib with doxorubicin as first-line treatment in elderly patients with metastatic or advanced soft tissue sarcoma (EPAZ): study protocol for a randomized controlled trial
46. The ONLINE-TICS Study Protocol: A Randomized Observer-Blind Clinical Trial to Demonstrate the Efficacy and Safety of Internet-Delivered Behavioral Treatment for Adults with Chronic Tic Disorders
47. Short- and long-term effects of the use of RAAS blockers immediately after renal transplantation
48. Non-invasive diagnosis of acute rejection in renal transplant patients using mass spectrometry of urine samples - a multicentre phase 3 diagnostic accuracy study
49. Assessing health-related quality of life in COPD: A comparison between one generic and two disease-specific instruments
50. Impact of peripheral artery disease on functional capacity in patients with COPD: Results of the COSYCONET study
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.